Scaling Stem-Cell Manufacturing for Therapies

As more than 100 clinical trials test human pluripotent stem cell-derived therapies, researchers are shifting focus from proving large-scale production is possible to building standardized, AI-enabled manufacturing systems capable of delivering consistent, clinically compliant cell products. The pos…

View Post on Scour ↗

More from GEN on Scour.

Rate this post to improve your feed:
🌰 Love  👍 Like  👎 Not for me